Medicare regulations may be causing shortage of cancer drugs

A month’s long shortage of cancer drugs may be the result of Medicare regulations. For several years, Medicare has provided coverage for cancer patients, allowing them to obtain treatments that they would otherwise have no access to. While Medicare offers this coverage, however, the number of cancer fighting drugs has been falling steadily. The phenomenon may be the result of a regulation within the Medicare system that dictates that doctors must purchase cancer drugs, not patients. Traditionally, patients have been responsible for purchasing their own medications as prescribed to them…

Read More

WellPoint shares drop following second quarter Medicare spending analysis

Shares of the health insurance company with the highest enrollment, WellPoint Inc., fell dramatically after the insurer announced that its second quarter medical care costs spiked following an increase in its Medicare patients. For the second time this year, the Indianapolis-based insurer has increased its annual forecast following the increase in sales. The enrollment with WellPoint increased by 2.1 percent, reaching 34.2 million, primarily from a rise in elderly and disabled Medicare members. Approximately 75 percent of the new enrollees with Medicare had come from competitors that had withdrawn from…

Read More